NEW YORK (Reuters) -Kimberly-Clark's nearly $50 billion offer for Tylenol maker Kenvue is a risky bet that the world's ...

Sarepta Therapeutics Inc. said a study designed to confirm the benefits of two of its older drugs for a devastating muscle ...

Six people have died and 25 people have been hospitalized due to a listeria outbreak linked to recalled precooked pasta meals ...

In any review of mifepristone, the FDA will now have to grapple with Judge Otake’s conclusion that the 2023 REMS decision for ...

Parents and clinicians are urged to review usage of certain health products for young children after federal authorities ...

The top drug regulator at the Food and Drug Administration (FDA) resigned Sunday, according to officials, after being accused ...

Brussels sprouts benefits include reducing the risk of diabetes and improving digestive health. Discover nine reasons you should eat Brussels sprouts.

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive consumer health goods company ...

A federal spokesperson said Dr. George Tidmarsh left the agency after federal lawyers began looking into “serious concerns ...

Supreme Produce brand peaches distributed between September and October, have been recalled by the Food and Drug ...

Enforcement action will be taken against any company marketing the products for children under the age of 3 or who are at low or moderate risk for tooth decay.